Skip to main content

Loading market ticker...

Is Rubicon Research Stock Nearing a Fresh 52-Week High?

Is Rubicon Research Stock Nearing a Fresh 52-Week High?

Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn More

Highlights

  • Rubicon Research shares jumped more than 8 percent in active trading.
  • The stock has gained over 90 percent on a year-to-date basis.
  • Shares remain close to their recently recorded 52-week high.

Shares of Rubicon Research Limited (NSE:RUBICON)  gained 8.43 percent on June 11, 2026, with the stock trading at INR 1,288.20 compared with the previous close of INR 1,188.10. The pharmaceutical company witnessed strong investor interest during the session, touching an intraday high of INR 1,312.70 and a low of INR 1,180.00.

The stock opened at INR 1,184.50 and remained in positive territory throughout the session. The volume-weighted average price (VWAP) stood at INR 1,263.52, reflecting active participation around current levels.

Stock Trades Near Record Annual High

Rubicon Research is currently trading close to its 52-week high of INR 1,370.00 recorded on June 2, 2026. The stock's 52-week low stands at INR 570.75, recorded on October 24, 2025.

At the current market price of INR 1,286.00, the stock is trading approximately 6.1 percent below its annual high and more than 125 percent above its 52-week low. The movement highlights the substantial appreciation witnessed over the past several months. The upper circuit limit for the stock is INR 1,425.70, while the lower circuit limit stands at INR 950.50.

Strong Momentum Reflects in Returns

Rubicon Research has significantly outperformed the broader market across several timeframes. Over the last month, the stock generated returns of 35.21 percent, while the NIFTY Total Market Index declined 2.58 percent during the same period.

The performance becomes even more notable on a year-to-date basis, with the stock advancing 90.17 percent compared with a 6.77 percent decline in the benchmark index.

Over the past week, however, the stock declined 0.90 percent despite the latest rally, while the NIFTY Total Market Index fell 1.38 percent. One-year, three-year and five-year return figures were not available in the disclosed exchange data.


      Source: NSE

Trading Volumes Remain Elevated

Rubicon Research recorded traded volume of 13.38 lakh shares, resulting in traded value of INR 169.09 crore during the session. The company had a total market capitalisation of INR 21,263.87 crore, while free-float market capitalisation stood at INR 2,916.70 crore.

The percentage of deliverable quantity to traded quantity was reported at 32.07 percent, indicating a combination of delivery-based and short-term market participation.

The stock's impact cost stood at 0.08, reflecting liquidity in trading activity.

Valuation and Volatility in Focus

Exchange data indicates that the stock's price-to-earnings ratio remains above 50 based on the previous four trailing quarters. The stock is also placed under ASM-1 surveillance, a framework used by exchanges to monitor stocks exhibiting specific trading characteristics.

Daily volatility stood at 2.20 percent, while annualised volatility was reported at 42.03 percent. These figures suggest that investors may continue to witness sizeable price movements over short periods.

Company Overview

Incorporated in 1999, Rubicon Research Limited is a pharmaceutical company engaged in the development, manufacturing and commercialisation of differentiated formulations. The company operates across pharmaceutical development and manufacturing segments and focuses on specialised drug delivery and formulation solutions.

Key Risks

  • High valuation levels may increase sensitivity to earnings performance.
  • ASM surveillance can influence trading activity and liquidity.
  • Pharmaceutical regulatory changes may affect business operations.
  • Elevated volatility can lead to significant short-term price swings.

Share Performance Today

Rubicon Research (NSE:RUBICON) shares traded at INR 1,288.20 on June 11, 2026, up INR 100 or 8.43 percent from the previous close of INR 1,188.10. The stock touched an intraday high of INR 1,312.70 and a low of INR 1,180.00. Traded volume stood at 13.38 lakh shares, while traded value reached INR 169.09 crore.


   Source: TradingView

Summary

Rubicon Research (NSE:RUBICON) shares gained 8.43percent on June 11, 2026, extending their recent upward momentum. The stock has delivered a year-to-date return of more than 90 percent and is trading close to its 52-week high of INR 1,370.00. Active trading volumes, a market capitalisation exceeding INR 21,000 crore and continued investor interest have kept the stock in focus. Investors may continue monitoring valuation metrics, volatility levels and future business developments.

FAQs

Q: How much did Rubicon Research shares gain on June 11, 2026?
A:
The stock rose 8.43percent to trade at INR 1,288.20 during the session.

Q: What is the 52-week high of Rubicon Research shares?
A:
The stock's 52-week high is INR 1,370.00, recorded on June 2, 2026.

Q: How has Rubicon Research performed in 2026 so far?
A:
The stock has gained 90.17 percent on a year-to-date basis.

Unlock Premium Articles for Exclusive Insights!

Disclaimer:

The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

Copyright 2026 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.